Aimedis is providing an innovative next-generation healthcare solution designed to connect patients to healthcare services and providers like doctors, hospitals and scientific research facilities. While competitors exist in this space, Aimedis is the only operational platform to integrate latest blockchain technology alongside artificial intelligence (AI). Aimedis is the only existing medical ecosystem combining professional healthcare knowledge with the swarm intelligence of patient communities.

Overview

Pre-Sale 05/15/2018 7 a.m. - 07/10/2018 11 p.m.
Token Sale Upcoming
Country Netherlands
B
Ben El Idrissi
COO, MD & FOUNDER
Member of this ICO only
Member of this ICO only
L
Lazaros Fountoukidis
CMO & MD
Participates in 2 ICOs
S
Stefan F. Krieg
PHYSICIST - HPC, DEEP LEARNING & AI
L
Lin Wan
HEAD OF IT & DEVELOPMENT
Member of this ICO only
A
Amer Mufti
HEAD OF SILICON VALLEY OFFICE - LEAD BLOCKCHAIN DEVELOPMENT
Member of this ICO only
S
Sebastian Wehkamp
CDO & CREATIVE DIRECTOR
Member of this ICO only
S
Sopia Singdee
BD ASIA
C
Catherine Angcaya
CFO
D
Daria Borisenko
BD RUSSIA, BELARUS & UKRAINE
Member of this ICO only
B
Bingfeng Liu
FULL STACK DEVELOPER
Participates in 2 ICOs
Z
Zilong Sun
FULL STACK MOBILE DEVELOPER
Member of this ICO only
M
Markus Moench
FULL STACK DEVELOPER
Member of this ICO only
G
Gang Zhu
FULL STACK DEVELOPER
Participates in 2 ICOs
Y
Yang Chul
BOERING PROJECTLEADER CARDIOLOGY & MD
M
Michael J. Kaldasch
CEO, MD & FOUNDER
Participates in 2 ICOs

Overview

Pre-Sale 05/15/2018 7 a.m. - 07/10/2018 11 p.m.
Token Sale Upcoming
Country Netherlands

Financial information

Platform Ethereum
Whitelist/KYC Whitelist & KYC
Token price 0.12 USD

Interest

Alexa rank 892,845 th
Telegram participants 27,808
Twitter followers 2,576
Promotional video views 13,159
Similar icos
Disclaimer

TrackICO does not encourage investing in any ICOs published on the platform. Make sure to do your own thorough research before putting money into Initial Coin Offerings. All content on TrackICO is meant to be used for information purposes only, and should not be taken as financial or investment advice.